Real Estate / REIT - Healthcare FacilitiesKuala Lumpur
$1.20
-0.03 (-2.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 22.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
17.1x
↑EV/EBITDA
21.1x
↑ROE
5.3%
↑Gross Margin
87.9%
↑Debt/Equity
0.96
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.9%
FCF CAGR
+6.4%
FCF margin
89.3%
FCF / Net income
1.92x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $120.0M · net income $55.7M · FCF $107.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $120.0M | $120.0M | $117.2M | $121.0M | $110.2M |
| Net Income | $55.7M | $55.7M | $58.3M | $60.7M | $60.1M |
| EBITDA | $93.7M | $93.7M | $95.0M | $97.4M | $86.2M |
| EPS | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 |
| Gross Margin | 87.9% | 87.9% | 88.2% | 89.2% | 90.4% |
| Operating Margin | 85.6% | 85.6% | 85.1% | 84.8% | 88.1% |
| Net Margin | 46.4% | 46.4% | 49.7% | 50.2% | 54.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.96 | 0.96 | 0.72 | 0.71 | 0.88 |
| Current Ratio | 0.33 | 0.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $107.2M | $107.2M | $96.0M | $101.3M | $88.9M |
| Returns | |||||
| ROE | 5.3% | 5.3% | 5.5% | 5.7% | 6.2% |
| Valuation | |||||
| P/E | 17.14 | 17.14 | 19.60 | 16.64 | 15.18 |
| EV/EBITDA | 21.10 | 21.10 | 19.65 | 17.61 | 20.04 |
| P/B | 0.96 | 0.96 | 1.08 | 0.94 | 0.94 |
| Growth & Yield | |||||
| Revenue Growth | 2.3% | 2.3% | -3.1% | 9.8% | — |
| EPS Growth | -4.3% | -4.3% | -6.8% | -8.8% | — |
| Dividend Yield | 6.4% | 6.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.0%
EPS terminal req.
$0.11
Spread vs growth
-21.4%
5Y implied EPS CAGR
14.2%
EPS terminal req.
$0.13
Spread vs growth
-18.5%
10Y implied EPS CAGR
12.1%
EPS terminal req.
$0.21
Spread vs growth
-16.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.4%
Start / end P/E
18.0x → 18.1x
EPS bridge
0.07 → 0.07
Residual
-0.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.